Ulipristal Impurity 13 - Names and Identifiers
Name | 19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5a,10a)-
|
Synonyms | Ulipristal Impurity 13 3,20-bis-ethylenedioxy-17α-hydroxy-19-norpregna-4,9-diene 3,20-Bis(ethylenedioxy)-19-norpregna-5(10)9(11)dien-17-ol 3,20-Bis(Ethylenedioxy)-19-Norpregna-5(10),9(11)-Dien-17-Ol 3,20-BIS(ETHYLENEDIOXY)-19-NORPREGNA-5(10),9(11)-DIENE-17-OL 3,20-bis-ethylenedioxy-17α-hydroxy-19-norpregna-5(10),9(11)-diene 3,3,20,20-bis-(ethylenedioxy)-19-norpregna-5(10),9(11)-dien-17α-ol 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-19-norpregna-5(10),9(11)-diene 3,3,20,20-bis(ehtylene-dioxy)-17a-hydroxy-19-norpregna-5(10),9(11)-diene 3,3,20,20-Bis(ethylene-dioxy)-17α-hydroxy-19-norpregna-5(10),9(11)-diene 17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal) 17-Hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione cyclic bis(1,2-ethanediyl acetal) 19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic bis(1,2-ethanediyl acetal) (9CI) 19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5a,10a)-
|
CAS | 54201-84-2
|
EINECS | 695-904-0 |
Ulipristal Impurity 13 - Physico-chemical Properties
Molecular Formula | C24H34O5
|
Molar Mass | 402.53 |
Density | 1.25 |
Boling Point | 562.1±50.0 °C(Predicted) |
pKa | 14.95±0.40(Predicted) |
Storage Condition | 2-8°C |
Ulipristal Impurity 13 - Introduction
19-Norpregna-5(10),9(11)-diene-3,20-dione,17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5a,10a)- (19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-10a acetonide-, cyclic 3, 20-benzene1 (acyl). Its chemical formula is C28H42O6 and its molecular weight is 474.64g/mol.
The properties of the compound can be described as follows:
-Appearance: colorless crystal or crystalline powder
-melting point: 173-176 ℃
-Solubility: Insoluble in water, soluble in organic solvents such as chloroform, dichloromethane and ethanol.
The main use of the compound is as a synthetic hormone (synthetic progesterone), which is commonly used in the medical field for contraceptives and treatment of diseases such as infertility, irregular menstruation, menopausal syndrome, etc.
on the preparation method, the specific steps are more complex, generally need to go through a multi-step synthesis. First, starting from certain compounds, through chemical reactions such as esterification, etherification, etc., the target compound is synthesized step by step.
Regarding safety information, since this is a synthetic compound, appropriate safety measures must be taken. This compound may have certain toxicity to human body, and specific safety information needs to be evaluated and handled with reference to the relevant safety data sheet (Safety Data Sheet) when used.
Please note that the information provided here is for reference only. For specific safety and application information, please refer to relevant research literature and professional guidance.
Last Update:2024-04-09 21:49:45